{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:38:29Z","timestamp":1778207909091,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.taap.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T10:15:46Z","timestamp":1390644946000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose"],"prefix":"10.1016","volume":"275","author":[{"given":"Hiroshi","family":"Honda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareta","family":"T\u00f6rnqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2014.01.010_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1085\/jgp.13.4.469","article-title":"Protein coagulation and its reversal. The preparation of insoluble globin, soluble globin and heme","volume":"13","author":"Anson","year":"1930","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.taap.2014.01.010_bb0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00204-013-1061-1","article-title":"Relative oral bioavailability of glycidol from glycidyl fatty acid esters in rats","volume":"87","author":"Appel","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb0015","unstructured":"As Tech Corporation, 2008. Method for preparation of glycidyl derivative. Japan Patent Kohyo 2008\u2013509991."},{"key":"10.1016\/j.taap.2014.01.010_bb0020","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jchromb.2008.11.028","article-title":"Quantification of N-(3-chloro-2-hydroxypropyl)valine in human haemoglobin as a biomarker of epichlorohydrin exposure by gas chromatography-tandem mass spectrometry with stable-isotope dilution","volume":"877","author":"Bader","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3891\/acta.chem.scand.44-0630","article-title":"Separation and enrichment of alkylated globin chains as a means of improving the sensitivity of hemoglobin adduct measurements","volume":"44","author":"Bergmark","year":"1990","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.taap.2014.01.010_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(01)00445-5","article-title":"Use of haemoglobin adducts in exposure monitoring and risk assessment","volume":"778","author":"Boogaard","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0272-0590(90)90207-Z","article-title":"4,4\u2032-Methylenebis(2-chloroaniline) (MOCA): comparison of macromolecular adduct formationafter oral or dermal administration in the rat","volume":"14","author":"Cheever","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0272-0590(87)90049-2","article-title":"Determination of erythrocyte life span in F-344, Wistar, and Sprague\u2013Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method","volume":"9","author":"Derelanko","year":"1987","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb9005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-1110(83)90024-6","article-title":"Dosimetry of genotoxic agents and dose-response relationships of their effects","volume":"123","author":"Ehrenberg","year":"1983","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb0045","first-page":"213","article-title":"A model for the formation and removal of hemoglobin adducts","volume":"1","author":"Fennell","year":"1992","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.taap.2014.01.010_bb0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/toxsci\/kfi069","article-title":"Metabolism and hemoglobin adduct formation of acrylamide in humans","volume":"85","author":"Fennell","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-2143(03)00086-6","article-title":"Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival","volume":"142","author":"Furne","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.taap.2014.01.010_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0027-5107(92)90014-S","article-title":"Degree of alkylation of macromolecules in vivo from variable exposure","volume":"284","author":"Granath","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb9000","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1539-6924.1999.tb00407.x","article-title":"Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model","volume":"19","author":"Granath","year":"1999","journal-title":"Risk Anal."},{"key":"10.1016\/j.taap.2014.01.010_bb0065","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.fct.2011.06.057","article-title":"Measurement of glycidol hemoglobin adducts in humans who ingest edible oil containing small amounts of glycidol fatty acid esters","volume":"49","author":"Honda","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb0070","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1016\/j.fct.2012.07.058","article-title":"Glycidol exposure evaluation of humans who have ingested diacylglycerol oil containing glycidol fatty acid esters using hemoglobin adducts","volume":"50","author":"Honda","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb0075","series-title":"Some Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 77","first-page":"469","article-title":"Glycidol","author":"IARC","year":"2000"},{"key":"10.1016\/j.taap.2014.01.010_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abio.1996.0322","article-title":"Biomonitoring of epichlorohydrin by hemoglobin adducts","volume":"240","author":"Landin","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2014.01.010_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0027-5107(97)00171-1","article-title":"Monitoring of occupational exposure to epichlorohydrin by genetic effects and hemoglobin adducts","volume":"381","author":"Landin","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0009-2797(98)00099-4","article-title":"Adducts with haemoglobin and with DNA in epichlorohydrin-exposed rats","volume":"117","author":"Landin","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2014.01.010_bb0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0278-6915(00)00093-4","article-title":"Heating of food and haemoglobin adducts from carcinogens: possible precursor role of glycidol","volume":"38","author":"Landin","year":"2000","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2014.01.010_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.toxlet.2009.07.030","article-title":"In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human","volume":"190","author":"Lav\u00e9","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2014.01.010_bb0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02772248609357133","article-title":"Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents","volume":"11","author":"Mowrer","year":"1986","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.taap.2014.01.010_bb0110","series-title":"NTP Technical Report No. 374; NIH Publ. No. 90-2829","article-title":"Toxicology and carcinogenesis studies of glycidol in F344\/N rats and B6C3F1 mice","author":"National Toxicology Program","year":"1990"},{"key":"10.1016\/j.taap.2014.01.010_bb0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15287399509531955","article-title":"Comparative disposition of 2,3-epoxy-1-propanol (glycidol) in rats following oral and intravenous administration","volume":"44","author":"Nomeir","year":"1995","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.taap.2014.01.010_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1539\/joh.48.314","article-title":"Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances","volume":"48","author":"Ogawa","year":"2006","journal-title":"J. Occup. Health"},{"key":"10.1016\/j.taap.2014.01.010_bb0125","series-title":"Diploma work","article-title":"Reaction kinetic characterization of glycidol: Cob(I)alamin as analytical tool","author":"Ohl\u00e9n","year":"2004"},{"key":"10.1016\/j.taap.2014.01.010_bb0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/taap.1998.8376","article-title":"Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene","volume":"150","author":"Osterman-Golkar","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.010_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0021-9673(01)88445-4","article-title":"Increasing thermospray response for cortisol by derivatization","volume":"554","author":"Paulson","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.taap.2014.01.010_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mrgentox.2004.11.006","article-title":"In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood","volume":"580","author":"Paulsson","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1383-5718(98)00106-5","article-title":"Comparison of ethylene, propylene and styrene 7,8-oxide in vitro adduct formation on N-terminal valine in human haemoglobin and on N-7-guanine in human DNA","volume":"418","author":"Pauwels","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/rtph.1994.1033","article-title":"In vivo tissue dosimetry as a basis for cross-species extrapolation in cancer risk assessment of propylene oxide","volume":"20","author":"Segerb\u00e4ck","year":"1994","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.010_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mrgentox.2004.11.004","article-title":"Reaction-kinetic parameters of glycidamide as determinants of mutagenic potency","volume":"580","author":"Silvari","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2014.01.010_bb0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.taap.2006.07.013","article-title":"Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide","volume":"217","author":"Tareke","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.01.010_bb0170","first-page":"650","article-title":"Epoxide adducts to N-terminal valine in hemoglobin","volume":"vol. 231B","author":"T\u00f6rnqvist","year":"1994"},{"key":"10.1016\/j.taap.2014.01.010_bb0175","series-title":"Biological Reactive Intermediates V","first-page":"275","article-title":"Ethylene oxide as a biological reactive intermediate of endogenous origin","author":"T\u00f6rnqvist","year":"1996"},{"key":"10.1016\/j.taap.2014.01.010_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0003-2697(86)90524-5","article-title":"Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method","volume":"154","author":"T\u00f6rnqvist","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2014.01.010_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1570-0232(02)00172-1","article-title":"Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications","volume":"778","author":"T\u00f6rnqvist","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0185","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1021\/jf800490s","article-title":"Approach for cancer risk estimation of acrylamide in food on the basis of animal cancer tests and in vivo dosimetry","volume":"56","author":"T\u00f6rnqvist","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2014.01.010_bb0190","series-title":"In Support of Summary Information on the Integrated Risk Information System (IRIS)","article-title":"Toxicological review of acrylamide","author":"US EPA","year":"2010"},{"key":"10.1016\/j.taap.2014.01.010_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/toxsci\/kfq323","article-title":"In vivo doses of acrylamide and glycidamide in humans after intake of acrylamide-rich food","volume":"119","author":"Vikstr\u00f6m","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2131\/jts.37.691","article-title":"Species differences in toxicokinetic parameters of glycidol after a single dose of glycidol or glycidol linoleate in rats and monkeys","volume":"37","author":"Wakabayashi","year":"2012","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.taap.2014.01.010_bb0205","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1021\/jo702401t","article-title":"Hot water-promoted ring-opening of epoxides and aziridines by water and other nucleopliles","volume":"73","author":"Wang","year":"2008","journal-title":"J. Org. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T03:21:05Z","timestamp":1538882465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X14000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0041008X14000180"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2014.01.010","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}